Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Aerobiology and pollution (2)
  • Artificial Intelligence (1)
  • Asthma (28)
  • Basic immunology (1)
  • x Biologicals (6)
  • Biomarkers (4)
  • COVID19 (1)
  • Dermatology (1)
  • ENT (2)
  • Environmental allergy and climate change (1)
  • Epidemiology (5)
  • Epithelial cell biology (1)
  • Immune deficiencies and autoimmunity (3)
  • Immunomodulation and nutrition (1)
  • Infections (4)
  • Mastocytosis and mast cells (1)
  • Microbiome (1)
  • Occupational allergy (3)
  • One Health (1)
  • Pediatrics (10)
  • Prevention (2)
Poster available until
Poster categories
  • Thematic Poster Session (1)
keywords
Session Reference
  • L-TPS02 (9)
  • L-TPS07 (11)
  • L-TPS08 (1)
  • L-TPS09 (3)
  • L-TPS10 (1)
  • L-TPS19 (1)
  • L-TPS21 (1)
  • TPS06 (8)
  • TPS09 (2)
  • TPS17 (4)
  • TPS18 (9)
  • TPS29 (1)
  • TPS51 (1)
  • TPS52 (5)
  • TPS55 (10)
  • x TPS56 (5)
  • x TPS57 (1)
  • TPS63 (1)
  • TPS67 (9)
  • TPS69 (2)
6 results
Thumbnail

- D3.114 - Does severe asthma exist in preschool children?

Thumbnail

- D3.116 - Mepolizumab as game changer in a case of severe occupational asthma with rhinitis and contact dermatitis

Thumbnail

- D3.117 - Targeting Mast Cells with Briquilimab, an Anti-Human c-Kit (CD117) Antibody, Mitigates COPD-Like Features in an Allergen and Cigarette Smoke-Exacerbated Asthma Model Using Humanized h/mCD117 Mice

Thumbnail

- D3.119 - Selection of Biologics for Severe Pediatric Asthma with Allergic Eosinophilic Phenotype

Thumbnail

- D3.123 - Dupilumab: Improved Asthma Control and Quality of Life in Pediatric Patients - A Real-World, Single-Center Study

Thumbnail

D3.138 - Asthma remission in EGPA patients: applicability and concordance of the main international guidelines

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM